3 TSX Stocks That Cratered up to 75% Recently: Should You Buy?

While markets at large have continued to soar higher, overvalued stocks have been punished awfully recently. Here are three TSX stocks that fell dramatically.

| More on:

Irrational exuberance has taken a massive hit in the last few months. While markets at large have continued to soar higher, overvalued stocks have been punished awfully recently. Here are three TSX stocks that have witnessed a huge fall.

Facedrive

The year 2020 was one of the worst years for the broader markets. But Canadian ride-hailer stock Facedrive (TSXV:FD) experienced an enormous ascent, gaining from $2 apiece early last year to $60 in February 2021. That’s a mindboggling 2,900% surge in just 14 months. However, the stock was even faster to drop, losing more than 75% in the last four-odd months.

Facedrive stock has seemed to have lost its sheen this year. Along with the stock price tumble, its daily trading volume has also dramatically dropped, indicating waning investor interest.

Facedrive has failed to prove its mettle on both operational as well as on the financial front. Its non-related business expansions and acquisitions merely hint at dragging away from its mainstay ride-sharing business.

Notably, FD stock still looks way expensive even after the recent fall. The company boasts a market cap of $1.4 billion but managed to earn revenues of just $7.8 million in the last 12 months. Importantly, the stock might remain weak until it sees visible revenue growth.

Trillium Therapeutics

Trillium Therapeutics (TSX:TRIL)(NASDAQ:TRIL) was one of the top performers last year, rising more than 3,000% in 2020. However, it has fallen to $11 levels this year from $27 a share from late last year.

Trillium Therapeutics is a $1.2 billion biotech company that develops innovative therapies for cancer treatment. Last year’s rally was mainly driven by two of its drug candidates that showed promising results in clinical trials. Biotech companies like Trillium are usually loss-making ventures. For Q1 2021, Trillium reported a loss of $10.6 million against a loss of $16 million in the prior quarter.

While investors are waiting for more data from Trillium on potential drug candidates, the stock has lost more than 60% this year. However, this kind of volatility in a small biotech stock is quite usual, making it a more suitable bet for aggressive investors.

Aurora Cannabis

Once an investor favourite, Aurora Cannabis (TSX:ACB)(NASDAQ:ACB) stock has failed to impress investors this year as well. It has lost more than 52% since its annual highs of $24 in February. In the last 12 months, ACB stock has lost almost 35%, while Horizons Medical Marijuana Life Sciences ETF has gained almost 40%.

The legalization prospects south of the border will likely bring substantial growth opportunities for the cannabis industry. However, challenges have beleaguered this high-growth sector. There has been a flurry of cannabis companies coming to the market, which led to the oversupply.

Aurora has been struggling to keep the top-line momentum for the last several quarters. It reported a significant revenue drop in the recreational segment in the latest quarter, which heavily dented investor sentiment.

When Aurora’s financials will improve is anybody’s guess. And that makes it a highly risky bet. Perhaps there are several other value bets that offer a better risk/reward proposition.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vineet Kulkarni has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

More on Stocks for Beginners

a man relaxes with his feet on a pile of books
Dividend Stocks

CPP Pensioners: Watch for These Important Updates

The CPP is an excellent tool for retirees, but be sure to stay on top of important updates like these.

Read more »

Piggy bank with word TFSA for tax-free savings accounts.
Stocks for Beginners

2 Top TSX Growth Stocks to Stash in a TFSA for Life

These two growth stocks may not be the top in the last month, but in the last few years, they…

Read more »

people relax on mountain ledge
Dividend Stocks

Invest $10,000 in This Dividend Stock for a Potential $4,781.70 in Total Returns

A dividend stock doesn't have to be risky, or without growth. And in the case of this one, the growth…

Read more »

TFSA (Tax free savings account) acronym on wooden cubes on the background of stacks of coins
Dividend Stocks

How to Turn a $15,000 TFSA Into $171,000

$15,000 may not seem like a lot, but over time that amount can balloon into serious cash.

Read more »

A worker uses a double monitor computer screen in an office.
Stocks for Beginners

Why I’d Buy Fairfax Financial Stock Even at Today’s Prices

Fairfax stock just keeps edging higher. But is it now too expensive, or can investors just look forward to even…

Read more »

Piggy bank in autumn leaves
Dividend Stocks

A 5.6% Dividend Yield? I’ll be Buying This TSX Stock for Decades!

This Big Six Bank offers a large dividend, growth strategy, and stability. In short, it offers it all!

Read more »

Concept of multiple streams of income
Stocks for Beginners

Lock Up This 9.2% Dividend Yield From a Top Royalty Stock

Royalty stocks have a strong advantage when it comes to creating passive income for investors. But this one has the…

Read more »

concept of real estate evaluation
Dividend Stocks

Buy 1,154 Shares of This Top Dividend Stock for $492.54/Month in Passive Income

This dividend stock can pay out top cash every month, sure, but has even more to look forward to.

Read more »